Use of Nanodropper vs. Standard Eyedropper in Patients With Glaucoma and Ocular Hypertension
Condition(s):Glaucoma, Open-Angle; Ocular HypertensionLast Updated:March 14, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Glaucoma, Open-Angle; Ocular HypertensionLast Updated:March 14, 2022Recruiting
Condition(s):Glaucoma, Open-Angle; Ocular HypertensionLast Updated:February 2, 2023Recruiting
Condition(s):Ocular HypertensionLast Updated:July 20, 2022Unknown status
Condition(s):Ocular HypertensionLast Updated:April 24, 2008Completed
Condition(s):Open-angle Glaucoma; Ocular HypertensionLast Updated:February 22, 2024Recruiting
Condition(s):Open-Angle Glaucoma; Ocular HypertensionLast Updated:November 3, 2011Completed
Condition(s):Primary Open Angle Glaucoma; Ocular HypertensionLast Updated:March 17, 2023Completed
Condition(s):Primary Open Angle Glaucoma; Ocular HypertensionLast Updated:February 27, 2023Completed
Condition(s):Glaucoma; Ocular HypertensionLast Updated:December 28, 2007Completed
Condition(s):Open-Angle Glaucoma; Ocular HypertensionLast Updated:February 13, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.